IPP expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.63336011382853E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.30820029756273E-10 |
Normal-vs-Stage2 |
6.25589999999621E-05 |
Normal-vs-Stage3 |
4.44089209850063E-16 |
Normal-vs-Stage4 |
1.62858615482264E-12 |
Stage1-vs-Stage2 |
9.121400E-01 |
Stage1-vs-Stage3 |
3.448300E-04 |
Stage1-vs-Stage4 |
2.039300E-04 |
Stage2-vs-Stage3 |
2.728100E-02 |
Stage2-vs-Stage4 |
1.383590E-02 |
Stage3-vs-Stage4 |
6.063600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.40998324127395E-14 |
Normal-vs-AfricanAmerican |
3.16869863681291E-11 |
Normal-vs-Asian |
1.863040E-01 |
Caucasian-vs-AfricanAmerican |
2.627400E-01 |
Caucasian-vs-Asian |
1.663810E-01 |
AfricanAmerican-vs-Asian |
5.473900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62458935193399E-12 |
Normal-vs-Female |
1.94259996977308E-09 |
Male-vs-Female |
5.638800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.21759999860416E-08 |
Normal-vs-Age(41-60Yrs) |
9.57900425646585E-12 |
Normal-vs-Age(61-80Yrs) |
1.64190883111814E-12 |
Normal-vs-Age(81-100Yrs) |
1.79369999964152E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.415570E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.029600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.174400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.426400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.280400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.939000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.958400E-01 |
Normal-vs-Grade 2 |
3.32229999067124E-09 |
Normal-vs-Grade 3 |
1.99840144432528E-15 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
1.044630E-01 |
Grade 1-vs-Grade 3 |
5.155300E-03 |
Grade 1-vs-Grade 4 |
1.55265999999266E-05 |
Grade 2-vs-Grade 3 |
2.957900E-03 |
Grade 2-vs-Grade 4 |
7.5852999992243E-08 |
Grade 3-vs-Grade 4 |
5.758300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.08680000000072E-05 |
Normal-vs-ccB subtype |
<1E-12 |
ccA subtype-vs-ccB subtype |
3.46889994506938E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.31770158620748E-12 |
Normal-vs-N1 |
3.93570000034593E-07 |
N0-vs-N1 |
1.856820E-01 |
|
|